Physician profile
Laura E Hicks
NPI 1902545080
$3,688.99
in general payments reported to CMS, 2019-2025
44 companies · $1,243 in 2025
The $1,243 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $222 · 2023: $863 · 2024: $1,361 · 2025: $1,243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,467.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $491.66 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $386.93 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $351.76 | 2022-2025 | |
| Abbvie INC. | $270.85 | 2023-2025 | |
| Exact Sciences Corporation | $270.60 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $256.97 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $156.61 | 2022-2025 | |
| Astellas Pharma US INC | $124.69 | 2024-2025 | Veozah |
| Xeris Pharmaceuticals, INC. | $122.21 | 2024-2025 | Gvoke Hypopen |
| Neos Therapeutics, LP | $118.67 | 2023-2024 | Adzenys Xr-Odt |
| Glaxosmithkline, LLC. | $104.35 | 2024-2025 | Bexsero, Arexvy, Shingrix |
| Corium, LLC | $96.97 | 2024-2025 | Azstarys |
| Dexcom, INC. | $83.78 | 2023-2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $58.37 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $56.92 | 2023-2025 | Xifaxan, Cycloset |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Hicks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.